Access
This article is part of Nature's premium content.
Published online 26 May 2009 |
Nature
| doi:10.1038/news.2009.515
Updated online: 27 May 2009
News
Draft stem-cell guidelines criticized
Researchers complain that previously approved cell lines would not be covered.
As the National Institutes of Health (NIH) begins finalizing guidelines to govern US funding of human embryonic stem-cell research, an initial ripple of researcher worry has swollen into a near-unanimous wave of concern that virtually all existing stem cell lines would be disqualified if the draft guidelines were adopted as written, with their strict informed-consent provisions.
During the 30-day period of public comment on the guidelines that ends today (26 May), the NIH received tens of thousands of comments.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
How about some news on the North Korea nuclear detonation? Instead all we see here is more blah blah about embryonic stem cells? GET WITH IT. There is more to science than federal $$.